Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Apr;48(4):1413-6.
doi: 10.1128/JCM.01409-09. Epub 2010 Feb 3.

Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification

F Damond  1 , V Avettand-Fenoel, G Collin, B Roquebert, J C Plantier, A Ganon, D Sizmann, R Babiel, J Glaubitz, M L Chaix, F Brun-Vezinet, D Descamps, C Rouzioux
Affiliations
Comparative Study

Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification

F Damond et al. J Clin Microbiol. 2010 Apr.

Abstract

We evaluated the performance of the prototype Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, using prospective and archived clinical samples initially underquantitated by the Cobas AmpliPrep/Cobas TaqMan HIV-1 test. The performance of the new test was significantly improved, and the majority of the underquantitation observed with the first-version test was eliminated.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Bland-Altman plots for comparisons between CAP/CTM v1.0, CAP/CTM v2.0, and CA/HIM v1.5 in a panel of 25 archived plasma samples. (A) Bland-Altman plot for the comparison between CAP/CTM v1.0 and CA/HIM v1.5 in 25 archived samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−2.29 and 0.62). (B) Bland-Altman plot for the comparison between CAP/CTM v2.0 and CA/HIM v1.5 in 25 archived samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−0.79 and 1.12). (C) Bland-Altman plot for the comparison between CAP/CTM v1.0 and CAP/CTM v2.0 in 25 archived samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−0.43 and 2.42).
FIG. 2.
FIG. 2.
Bland-Altman plots for comparisons between CAP/CTM v1.0, CAP/CTM v2.0, and CA/HIM v1.5 in a panel of prospectively collected plasma samples. (A) Bland-Altman plot for the comparison between CAP/CTM v1.0 and CA/HIM v1.5 in 259 valid result pairs for a panel of prospective routine clinical samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−0.92 and 0.62). (B) Bland-Altman plot for the comparison between CAP/CTM v2.0 and CA/HIM v1.5 in 259 valid result pairs for a panel of prospective routine clinical samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−0.50 and 0.65). (C) Bland-Altman plot for the comparison between CAP/CTM v1.0 and CAP/CTM v2.0 (HIV-1 v2.0) in 259 valid result pairs for a panel of prospective routine clinical samples. The broken line indicates the mean log10 difference, and the dotted lines represent the borders of the 95% confidence intervals (−0.46 and 0.90).
See this image and copyright information in PMC

References

    1. Alaeus, A., K. Lidman, A. Sonnerborg, and J. Albert. 1997. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865. - PubMed
    1. Berger, A., L. Scherzed, M. Sturmer, W. Preiser, H. W. Doerr, and H. F. Rabenau. 2002. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation). J. Clin. Virol. 25(Suppl. 3):S103-S107. - PubMed
    1. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310. - PubMed
    1. Damond, F., C. Apetrei, D. Descamps, F. Brun-Vezinet, and F. Simon. 1999. HIV-1 subtypes and plasma RNA quantification. AIDS 13:286-288. - PubMed
    1. Damond, F., B. Roquebert, A. Benard, G. Collin, M. Miceli, P. Yeni, F. Brun-Vezinet, and D. Descamps. 2007. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche Cobas AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays. J. Clin. Microbiol. 45:3436-3438. - PMC - PubMed

Substances